Dr. Carolyn Anderson’s new R01, “PET Probes Targeting Immune Cells for Imaging Tuberculosis” was recently recommended for funding. This study will develop new PET imaging probes that target activated macrophages and neutrophils found in TB lesions, which could eventually lead to more accurate diagnoses and techniques to assess treatment response.
Dr. Panigrahy has been awarded an R01 to study the brain connectcome and neurodevelopmental outcomes in pediatric patients with congenital heart disease. The goal of this study is to evaluate the association between alterations in brain networks and neurocognitive deficits in Fontan survivors to better understand the role of developing neural architecture in cognitive-behavioral phenotypes.